• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从 SF-36v2 开发 SF-6D 健康状态分类系统新版本:SF-6Dv2。

Developing a New Version of the SF-6D Health State Classification System From the SF-36v2: SF-6Dv2.

机构信息

School of Health and Related Research, University of Sheffield, Sheffield, UK.

Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, NSW, Australia.

出版信息

Med Care. 2020 Jun;58(6):557-565. doi: 10.1097/MLR.0000000000001325.

DOI:10.1097/MLR.0000000000001325
PMID:32412942
Abstract

OBJECTIVE

The objective of this study was to develop the classification system for version of the SF-6D (SF-6Dv2) from the SF-36v2. SF-6Dv2 is an improved version of SF-6D, one of the most widely used generic measures of health for the calculation of quality-adjusted life years.

STUDY DESIGN AND SETTING

A 3-step process was undertaken to generate a new classification system: (1) factor analysis to establish dimensionality; (2) Rasch analysis to understand item performance; and (3) tests of differential item function. To evaluate robustness, Rasch analyses were performed in multiple subsets of 2 large cross-sectional datasets from recently discharged hospital patients and online patient samples.

RESULTS

On the basis of factor analysis, other psychometric evidence, cross-cultural considerations, and amenability to valuation, the 6-dimension classification used in SF-6D was maintained. SF-6Dv2 resulted in the following modifications to SF-6D: a simpler classification of physical function with clearer separation between levels; a more detailed 5-level description of role limitations; using negative wording to describe vitality; and using pain severity rather than pain interference.

CONCLUSIONS

The SF-6Dv2 classification system describes more distinct levels of health than SF-6D, changes the descriptions used for a number of dimensions and provides clearer wording for health state valuation. The second stage of the study has developed a utility value set using discrete choice methods so that the measure can be used in health technology assessment. Further work should investigate the psychometric characteristics of the new instrument.

摘要

目的

本研究旨在开发 SF-6D(SF-6Dv2)的版本分类系统,SF-6Dv2 是 SF-6D 的一个改进版本,SF-6D 是最常用于计算质量调整生命年的通用健康衡量标准之一。

研究设计与设置

采用三步法生成新的分类系统:(1)因子分析以确定维度;(2)Rasch 分析以了解项目表现;(3)差异项目功能测试。为了评估稳健性,在最近出院的医院患者和在线患者样本的 2 个大型横断面数据集的多个子集中进行了 Rasch 分析。

结果

基于因子分析、其他心理测量证据、跨文化考虑因素以及估值的适应性,SF-6D 中使用的 6 维度分类得以保留。SF-6Dv2 对 SF-6D 进行了以下修改:物理功能的分类更简单,水平之间的分离更清晰;角色限制的 5 级描述更详细;使用负面措辞描述活力;以及使用疼痛严重程度而不是疼痛干扰。

结论

SF-6Dv2 分类系统比 SF-6D 更能描述健康的不同水平,改变了许多维度使用的描述,并为健康状况估值提供了更清晰的措辞。研究的第二阶段使用离散选择方法开发了效用值集,以便该测量方法可用于卫生技术评估。进一步的工作应研究新工具的心理测量特征。

相似文献

1
Developing a New Version of the SF-6D Health State Classification System From the SF-36v2: SF-6Dv2.从 SF-36v2 开发 SF-6D 健康状态分类系统新版本:SF-6Dv2。
Med Care. 2020 Jun;58(6):557-565. doi: 10.1097/MLR.0000000000001325.
2
Valuing the SF-6Dv2 Classification System in the United Kingdom Using a Discrete-choice Experiment With Duration.采用具有持续时间的离散选择实验评估英国的 SF-6Dv2 分类系统
Med Care. 2020 Jun;58(6):566-573. doi: 10.1097/MLR.0000000000001324.
3
Consistency Between Three Different Ways of Administering the Short Form 6 Dimension Version 2.三种不同方式施测短式 6 维度版本 2 的一致性。
Value Health. 2019 Jul;22(7):837-842. doi: 10.1016/j.jval.2018.12.012. Epub 2019 May 17.
4
A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population.SF-6Dv2 与 SF-6D UK 效用值在混合患者和健康人群中的比较。
Pharmacoeconomics. 2021 Aug;39(8):929-940. doi: 10.1007/s40273-021-01033-6. Epub 2021 May 27.
5
Creating an SF-6Dv2 social value set for New Zealand.为新西兰制定 SF-6Dv2 社会价值集。
Soc Sci Med. 2024 Aug;354:117073. doi: 10.1016/j.socscimed.2024.117073. Epub 2024 Jun 26.
6
Valuing the SF-6Dv2 in the capital of Iran using a discrete choice experiment with duration.使用具有持续时间的离散选择实验来评估伊朗首都的 SF-6Dv2。
Qual Life Res. 2024 Jul;33(7):1853-1863. doi: 10.1007/s11136-024-03649-5. Epub 2024 Apr 17.
7
The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.开发一种将 Neck Disability Index (NDI)转化为颈椎疾病成本效用分析中效用评分的模型。
Spine J. 2012 Jan;12(1):55-62. doi: 10.1016/j.spinee.2011.12.002. Epub 2011 Dec 29.
8
Unchained melody: revisiting the estimation of SF-6D values.《奔放的旋律》:重新审视SF-6D值的估算
Eur J Health Econ. 2016 Sep;17(7):865-73. doi: 10.1007/s10198-015-0727-4. Epub 2015 Sep 10.
9
Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population.SF-6Dv2 在伊朗乳腺癌人群中的心理测量特性。
Breast Cancer. 2021 Jul;28(4):937-943. doi: 10.1007/s12282-021-01230-3. Epub 2021 Mar 5.
10
Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.使用多发性硬化症影响量表来估算健康状态效用值:从 MSIS-29 版本 2 到 EQ-5D 和 SF-6D 的映射。
Value Health. 2012 Dec;15(8):1084-91. doi: 10.1016/j.jval.2012.07.007. Epub 2012 Nov 4.

引用本文的文献

1
Methodology of the international cross-sectional prevalence and severity study of pediatric and adult IgE-mediated food allergies (ASSESS FA).儿童及成人IgE介导的食物过敏国际横断面患病率及严重程度研究(ASSESS FA)的方法学
World Allergy Organ J. 2025 Aug 22;18(9):101105. doi: 10.1016/j.waojou.2025.101105. eCollection 2025 Sep.
2
Mapping the EORTC QLQ-C30 and QLQ-LC13 to the SF-6D utility index in patients with lung cancer using machine learning and traditional regression methods.运用机器学习和传统回归方法将欧洲癌症研究与治疗组织核心生活质量问卷(EORTC QLQ-C30)及肺癌模块问卷(QLQ-LC13)映射到肺癌患者的SF-6D效用指数。
Health Qual Life Outcomes. 2025 Jul 1;23(1):66. doi: 10.1186/s12955-025-02394-8.
3
The Psychometric Performance of Generic Preference-Based Measures in Informal Carers: A Systematic Review of Validation Studies.
通用偏好性测量工具在非正式照料者中的心理测量性能:验证研究的系统评价
Pharmacoeconomics. 2025 Jun 28. doi: 10.1007/s40273-025-01509-9.
4
Convergent validity, reliability and responsiveness of the AP-7D and EQ-5D-5L based on the survey for the general people in five countries: a new cultural-specific preference-based measure developed in east and southeast asia.基于五个国家普通人群调查的AP - 7D和EQ - 5D - 5L的收敛效度、信度和反应度:一种在东亚和东南亚开发的基于特定文化偏好的新测量方法
Health Qual Life Outcomes. 2025 Jun 13;23(1):61. doi: 10.1186/s12955-025-02393-9.
5
Psychometric validation and cultural adaptation of the Chinese version of the CarerQol-7D instrument.中文版CarerQol-7D量表的心理测量学验证及文化调适
Health Qual Life Outcomes. 2025 May 9;23(1):49. doi: 10.1186/s12955-025-02379-7.
6
Mapping the ADDQoL to the EQ-5D-5L and SF-6Dv2 among Chinese patients with type 2 diabetes mellitus.在中国2型糖尿病患者中,将糖尿病患者生活质量评估量表(ADDQoL)映射到欧洲五维健康量表(EQ-5D-5L)和简明健康效用指数6D第2版(SF-6Dv2)。
Health Qual Life Outcomes. 2025 Apr 30;23(1):46. doi: 10.1186/s12955-025-02371-1.
7
Validation of the Cancer-Specific Preference-Based Measure EORTC QLU-C10D against the Generic Instruments EQ-5D-5L and SF-6Dv2 in a Prospectively Collected Sample of Patients with Cancer in Austria and France.在奥地利和法国前瞻性收集的癌症患者样本中,基于癌症特异性偏好的测量指标EORTC QLU-C10D相对于通用工具EQ-5D-5L和SF-6Dv2的验证。
Pharmacoeconomics. 2025 Apr 27. doi: 10.1007/s40273-025-01501-3.
8
A framework for extending the health-related quality adjusted life year by combining instruments.一种通过整合工具来扩展与健康相关的质量调整生命年的框架。
Health Qual Life Outcomes. 2025 Mar 24;23(1):25. doi: 10.1186/s12955-025-02352-4.
9
Immediate Death: Not So Bad If You Discount the Future but Still Worse than It Should Be.猝死:如果你不考虑未来,倒也不算太糟,但仍比应有的情况更糟糕。
Med Decis Making. 2025 May;45(4):376-384. doi: 10.1177/0272989X251325828. Epub 2025 Mar 20.
10
Integration of a Patient-Centered mHealth Intervention (Support-Moms) Into Routine Antenatal Care to Improve Maternal Health Among Pregnant Women in Southwestern Uganda: Protocol for a Randomized Controlled Trial.将以患者为中心的移动健康干预措施(支持妈妈)纳入乌干达西南部孕妇的常规产前护理以改善孕产妇健康:一项随机对照试验的方案
JMIR Res Protoc. 2025 Mar 19;14:e67049. doi: 10.2196/67049.